CSIMarket
 


Perkinelmer Inc  (PKI)
Other Ticker:  
 
 

PKI's Revenue Growth by Quarter and Year

Perkinelmer Inc's Revenue results by quarter and year




PKI Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter January - 3,738.36 531.90 572.92
III Quarter October - 608.39 524.28 509.60
II Quarter July - 542.05 543.30 521.79
I Quarter April 1,259.44 556.17 505.38 510.89
FY   1,259.44 5,444.97 2,104.86 2,115.20



PKI Revenue first quarter 2021 Y/Y Growth Comment
Perkinelmer Inc achieved in the first quarter 2021, above Company average Revenue surge of 126.45% year on year, to $ 1,259.44 millions.

Among companies who have reported first quarter 2021 results in the Laboratory Analytical Instruments industry only one Company has achieved higher year on year Revenue results in the first quarter 2021. While Perkinelmer Inc' s Revenue doubling of 126.45% ranks overall at the positon no. 305 in the first quarter 2021.




PKI Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter January - 602.83 % -7.16 % 6.06 %
III Quarter October - 16.04 % 2.88 % 12.31 %
II Quarter July - -0.23 % 4.12 % 8.82 %
I Quarter April 126.45 % 10.05 % -1.08 % 14.07 %
FY   - 158.69 % -0.49 % 10.09 %

Financial Statements
Perkinelmer Inc's first quarter 2021 Revenue $ 1,259.44 millions PKI's Income Statement
Perkinelmer Inc's first quarter 2020 Revenue $ 556.17 millions Quarterly PKI's Income Statement
New: More PKI's historic Revenue Growth >>


PKI Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter January - 514.47 % 1.45 % 12.43 %
III Quarter October - 12.24 % -3.5 % -2.34 %
II Quarter July - -2.54 % 7.5 % 2.13 %
I Quarter April -66.31 % 4.56 % -11.79 % -5.42 %
FY (Year on Year)   - 158.69 % -0.49 % 10.09 %




Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #23
Overall #305

Revenue Y/Y Growth Statistics
High Average Low
17.32 % 1.8 % -6.7 %
(Apr 04 2021)   (Jan 01 2017)
Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #23
Overall #305
Revenue Y/Y Growth Statistics
High Average Low
17.32 % 1.8 % -6.7 %
(Apr 04 2021)   (Jan 01 2017)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Perkinelmer Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
40.52 % 0.76 % -100 %
(Jan 03 2021)  


PKI's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2021 Perkinelmer Inc disclosed fall in Revenue from the fourth quarter by -66.31% to $ 1,259.44 millions, from $ 3,738.36 millions released in the previous quarter.

Although periodic circumstance normally fuel I. Quarter 2021 results, this simply was not enough to recover PKI's achievement, Elisa Dubois, market advisor situated in Brussel pointed out and continued that average sequential Revenue growth is at 0.76% for Perkinelmer Inc.

Within Laboratory Analytical Instruments industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Perkinelmer Inc's Revenue growth quarter on quarter, overall rank is 2101.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #8
Healthcare Sector #238
Overall #2101
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #8
Healthcare Sector #238
Overall #2101
Revenue Q/Q Growth Statistics
High Average Low
40.52 % 0.76 % -100 %
(Jan 03 2021)  


PKI's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2021 Perkinelmer Inc reported fall in Revenue from the previous quarter by -66.31% to $ 1,259.44 millions, from $ 3,738.36 millions released in the previous quarter.

Although seasonal influence usually fuel I. Quarter 2021 results, this simply has not been sufficient to recover Perkinelmer Inc's outcome, Elisa Dubois, market advisor situated in Brussel said.

Within Laboratory Analytical Instruments industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Perkinelmer Inc's Revenue growth quarter on quarter, overall rank is 2101.


Perkinelmer Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Apr 03 2022)
12 Months Ending
(Jan 02 2022)
12 Months Ending
(Sep. 30, 2015)
12 Months Ending
IV. Quarter
12 Months Ending
IV. Quarter
Cumulative Revenue 12 Months Ending $ 2,966.05 $ 0.00 $ 2,262.63 $ 2,238.51 $ 2,238.51
Y / Y Revenue Growth (TTM) 40.91 % - 1.76 % 4.32 % 4.32 %
Year on Year Revenue Growth Overall Ranking # 288 # 419 # 831 # 956 # 1332
Seqeuential Revenue Change (TTM) 32.5 % - 0.95 % 3.9 % 3.9 %
Seq. Revenue Growth (TTM) Overall Ranking # 941 # 441 # 572 # 638 # 1211




Cumulative Revenue growth Comment
Perkinelmer Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 40.91% year on year, to $ 2,966 millions if the fiscal year would have ended in Apr 03 2022.
Perkinelmer Inc's trailing twelve months Revenue growth was higher than company's average 5.57% and higher than % growth in Jan 02 2022.
But from the previous reporting period increase was less at 32.5 % from $2238.51 millions recorded in twelve months ending a quarter before.
Yet this was validation of positive momentum, as the usual sequential growth is at 1.93%.
The momentum was even higher sequentially showed at 32.5 % increase from $2238.51 millions in the period from Jan 02 2022 to IV. Quarter.

Within the Healthcare sector 31 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 288, from total ranking in previous quarter at 419.

Revenue TTM Q/Q Growth Statistics
High Average Low
17.32 %
1.93 %
-6.7 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 4
Healthcare Sector # 32
Overall # 288

Revenue TTM Y/Y Growth Statistics
High Average Low
53.71 %
5.57 %
-11.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 84
S&P 500 # 941
Cumulative Revenue growth Comment
Perkinelmer Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 40.91% year on year, to $ 2,966 millions if the fiscal year would have ended in Apr 03 2022.
Perkinelmer Inc's trailing twelve months Revenue growth was higher than company's average 5.57% and higher than % growth in Jan 02 2022.
But from the previous reporting period rise was less at 32.5 % from $2238.51 millions achieved in twelve months ending a quarter before.
Still it was validation of positive momentum, as the average Q/Q TTM growth stands at 1.93%.
The progress was much stronger from the previous reporting period clinched at 32.5 % increase from $2238.51 millions in the period from Jan 02 2022 to IV. Quarter.

Within the Healthcare sector 31 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 288, from total ranking in previous quarter at 419.

Revenue TTM Q/Q Growth Statistics
High Average Low
17.32 %
1.93 %
-6.7 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 4
Healthcare Sector # 32
Overall # 288

Revenue TTM Y/Y Growth Statistics
High Average Low
53.71 %
5.57 %
-11.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 84
S&P 500 # 941




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PKI's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PKI's Competitors
Revenue Growth for Perkinelmer Inc's Suppliers
Revenue Growth for PKI's Customers

You may also want to know
PKI's Annual Growth Rates PKI's Profitability Ratios PKI's Asset Turnover Ratio PKI's Dividend Growth
PKI's Roe PKI's Valuation Ratios PKI's Financial Strength Ratios PKI's Dividend Payout Ratio
PKI's Roa PKI's Inventory Turnover Ratio PKI's Growth Rates PKI's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Apr 03 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Apr 03 2022
Pfizer Inc75.98%$ 75.977 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com